William's mailing address filed with the SEC is C/O ADURO BIOTECH, INC., 740 HEINZ AVENUE, BERKELEY, CA, 94710.
Over the last 11 years, insiders at Biocept Inc have traded over 2,456$ worth of Biocept Inc stock and bought 1,703,300 units worth 1,869,312$ . The most active insiders traders include Claire Reiss、Edward A. Neff、David F Hale. On average, Biocept Inc executives and independent directors trade stock every 92 days with the average trade being worth of 27,462$. The most recent stock trade was executed by David F Hale on 9 December 2021, trading 445 units of BIOC stock currently worth 1,807$.
biocept is a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor associated dna , both in circulating tumor cells (ctcs) and in plasma (cell free circulating tumor dna). our mission is to improve outcomes for cancer patients by advancing oncology diagnostics. we utilize patented and innovative technologies to deliver clinically relevant oncology diagnostics to physicians by providing advanced prognostic and predictive assessments for guiding the course of treating patients. additionally, we offer services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies, and clinical trial support. our strategic focus is to promote our unique targeted selector™ technology to the oncology community. our target selector technology has demonstrated that it can consistently capture extremely rare cells which may be present in only 1 of every 50-100 billion blood cells. examples of these rare cells ar
Biocept Inc executives and other stock owners filed with the SEC include: